TransMedics Group, Inc. (TMDX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$27.18M
Year ended 2025-12-31
$36.42M
Trailing 12 months to 2026-06-30
+98.5%
3-year compound annual growth
+76.7%
5-year compound annual growth
2018-12-29: $769.0K2019-12-28: $1.22M2020-12-31: $1.58M2021-12-31: $1.82M2022-12-31: $3.48M2023-12-31: $8.18M2024-12-31: $19.76M2025-12-31: $27.18M$27.18M
2018-12-29 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$27.18M+37.6%2026-02-24, From 2025-01-01
2024-12-31$19.76M+141.6%2026-02-24, From 2024-01-01
2023-12-31$8.18M+135.1%2026-02-24, From 2023-01-01
2022-12-31$3.48M+91.4%2025-02-27, From 2022-01-01
2021-12-31$1.82M+15.2%2024-02-27, From 2021-01-01
2020-12-31$1.58M+29.1%2023-02-27, From 2019-12-29
2019-12-28$1.22M+58.9%2021-03-11, From 2018-12-30
2018-12-29$769.0Kn/a2020-03-17, From 2017-12-31

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
TransMedics Group, Inc. (TMDX)2025-12-31$27.18M+37.6%
InMode Ltd. (INMD)2025-12-31$695.0K-4.5%
Axogen, Inc. (AXGN)2025-12-31$6.66M+3.0%
Integer Holdings Corp (ITGR)2025-12-31$130.67M+17.7%
Outset Medical, Inc. (OM)2025-12-31$4.34M-24.2%
Biolife Solutions Inc (BLFS)2025-12-31$2.25M-56.3%
Vaso Corp (VASO)2025-12-31$858.0K+4.1%
Ceribell, Inc. (CBLL)2025-12-31$1.34M+17.5%
Iridex Corp (IRIX)2026-01-03$523.0K-10.4%

Compare TMDX, INMD, AXGN, ITGR side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗